Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.62 |
| ▸ | PPARD | Q03181 | 5/20 | 0.62 |
| ▸ | PPARA | Q07869 | 5/20 | 0.62 |
| ▸ | F7 | P08709 | 5/20 | 0.62 |
| ▸ | F3 | P13726 | 5/20 | 0.62 |
| ▸ | TERT | O14746 | 3/20 | 0.62 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | FABP4 | P15090 | 3/20 | 0.62 |
| ▸ | TOP1 | P11387 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.62 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.62 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.62 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.62 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933603 | 1.00 | PPARG (0.62) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL933601 | 1.00 | PPARG (0.62) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL933504 | 1.00 | PPARG (0.62) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL934025 | 0.97 | PPARG (0.62) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL934023 | 0.97 | PPARG (0.62) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL22282518 | 0.94 | FAAH (0.55) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL953225 | 0.93 | PPARG (0.59) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL953224 | 0.93 | PPARG (0.59) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL1047282 | 0.92 | KMT2A (0.59) | PPARGPPARDPPARAPTPN1HSD17B10 | |
| SCHEMBL1047699 | 0.92 | KMT2A (0.59) | PPARGPPARDPPARAPTPN1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734964-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2025007024-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2025-01-02 | — | — | WO | claimed |
| US-20160151282-A1 | AMPHOTERIC LIPOSOME FORMULATIONS | MARINA BIOTECH INC (US) | 2016-06-02 | — | — | US | claimed |
| US-9283186-B2 | Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome | MARINA BIOTECH, INC. (US) | 2016-03-15 | — | — | US | claimed |
| EP-4734964-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4727969-A2 | METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION | Rethink64 Bionetworks PBC (US) | 2026-04-22 | — | — | EP | disclosed |
| WO-2025007024-A1 | LIPID PARTICLES FOR DELIVERING A PAYLOAD | Repertoire Immune Medicines, Inc. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024259374-A2 | METHODS FOR PROVIDING INTERCELLULAR COMMUNICATION | RETHINK64 BIONETWORKS PBC (US) | 2024-12-19 | — | — | WO | disclosed |
| US-20240389602-A1 | LIPOSOME FORMULATIONS FOR PESTICIDE DELIVERY AND METHODS FOR PRODUCING AND USING THE SAME | SUTERRA LLC | 2024-11-28 | — | — | US | disclosed |
| US-11541010-B2 | Amphoteric liposomes comprising imino lipids | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2023-01-03 | — | — | US | disclosed |
| US-20200330384-A1 | AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2020-10-22 | — | — | US | disclosed |
| EP-2823810-B9 | Amphoteric liposomes comprising imino lipids | NOVOSOM VERWALTUNGS GMBH (DE) | 2019-10-30 | — | — | EP | disclosed |
| EP-2125031-A2 | LIPIDS AND LIPID ASSEMBLIES COMPRISING TRANSFECTION ENHANCER ELEMENTS | Novosom AG (DE) | 2009-12-02 | — | — | EP | disclosed |
| EP-2094238-A2 | IMPROVEMENTS IN OR RELATING TO AMPHOTERIC LIPOSOMES | Novosom AG (DE) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009047006-A2 | AMPHOTERIC LIPOSOMES COMPRISING NEUTRAL LIPIDS | NOVOSOM AG (DE) | 2009-04-16 | — | — | WO | disclosed |
| WO-2008155141-A2 | NOVEL FACULTATIVE CATONIC STEROLS | NOVOSOM AG (DE) | 2008-12-24 | — | — | WO | disclosed |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | CEQUENT PHARMACEUTICALS, INC. | 2008-12-11 | — | — | US | disclosed |
| WO-2008074487-A2 | LIPIDS AND LIPID ASSEMBLIES COMPRISING TRANSFECTION ENHANCER ELEMENTS | NOVOSOM AG (DE) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008043575-A2 | IMPROVEMENTS IN OR RELATING TO AMPHOTERIC LIPOSOMES | NOVOSOM AG (DE) | 2008-04-17 | — | — | WO | disclosed |
| US-20080089932-A1 | Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome | MARINA BIOTECH, INC. | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11541010-B2 | Amphoteric liposomes comprising imino lipids | SGMS1, SGMS2, PHOSPHO1 | PPARG 3547/4885PPARD 3364/4885PPARA 2871/4885 |
| US-20080306153-A1 | Lipids and lipid assemblies comprising transfection enhancer elements | SREBF1, SREBF2, ELOVL1 | PPARG 521/4885PPARD 1832/4885PPARA 869/4885 |
| US-20200330384-A1 | AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS | SGMS1, SGMS2, PHOSPHO1 | PPARG 3547/4885PPARD 3364/4885PPARA 2871/4885 |
| US-20160151282-A1 | AMPHOTERIC LIPOSOME FORMULATIONS | LIPA, SGMS1, SGMS2 | PPARG 3393/4885PPARD 3678/4885PPARA 2630/4885 |
| US-20080089932-A1 | Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome | LIPA, SGMS1, SGMS2 | PPARG 4048/4885PPARD 4181/4885PPARA 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.